Sign in
Budget impact analysis of the use of daclatasvir for the treatment of Hepatitis C virus (HCV) Genotypes 3, in the Italian setting
Conference proceeding   Peer reviewed

Budget impact analysis of the use of daclatasvir for the treatment of Hepatitis C virus (HCV) Genotypes 3, in the Italian setting

Umberto Restelli, Marzia Bonfanti, Alfredo Alberti, Adriano Lazzarin, Carmela Nappi and Davide Croce
Value in health, Vol.18, pp.A580-A580
ISPOR 18th Annual European Congress (Milan, 07/11/2015 - 11/11/2015)
2015
Web of Science ID: WOS:000209861300418
pdf
bitstream_dfd67cc3-1882-44e9-afd3-50808356fb4149.96 kB
Ask the Library / Chiedi alla Biblioteca Restricted Access

Metrics

1 File views/ downloads
18 Record Views

Details